CARDEA
LIVE

Serial Number

88317443

Owner

CARDEA BIO, INC.

Attorney

Jesse A. Salen

First Use Date

Oct 29, 2019

Filing Date

Feb 26, 2019

Add to watchlist:

No watchlists yet
View on USPTO

CARDEA Trademark

Serial Number: 88317443 • Registration: 6222646

CARDEA is a trademark filed by CARDEA BIO, INC. on February 26, 2019. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

CARDEA BIO, INC. (11 trademarks)

8969 KENAMAR DRIVE, SUITE 104
SAN DIEGO, CA 92121

Entity Type: 03

Nanomedical Diagnostics, Inc. (9 trademarks)

4225 Executive Square, Suite 480
San Diego, CA 92037

Entity Type: 03

Trademark Details

Filing Date

February 26, 2019

Registration Date

December 15, 2020

First Use Anywhere

October 29, 2019

First Use in Commerce

August 6, 2020

Published for Opposition

February 11, 2020

Goods & Services

Medical diagnostic instruments, namely, medical instruments in the nature of electronic analyzers for the analysis of small biomolecules, biomolecule fragments, proteins, peptides, or aptamers; medical apparatus and instrument for diagnostic use, namely, electronic analyzers for medical diagnostic testing of body fluids, small biomolecules, biomolecule fragments, proteins, peptides, or aptamers; diagnostic kits consisting of electronic analyzers for the analysis of small biomolecules, biomolecule fragments, proteins, peptides, or aptamers; diagnostic kits comprised primarily of medical instruments in the nature of biosensors, for testing of body fluids, bio samples, liquid samples, organic samples, non-organic samples, small biomolecules, biomolecule fragments, proteins, peptides, or aptamers; medical test kits consisting of electronic analyzers for testing of biological samples

Scientific apparatus in the nature of research laboratory analyzers for testing biological samples, namely, body fluids, bio-samples, liquid samples, organic samples, non-organic samples, small biomolecules, biomolecule fragments, proteins, peptides, or aptamers; Scientific instruments in the nature of research laboratory analyzers for testing biological samples, namely, body fluids, bio-samples, liquid samples, organic samples, non-organic samples, small biomolecules, biomolecule fragments, proteins, peptides, or aptamers; scientific apparatus in the nature of, computer hardware for diagnostic testing of body fluids, bio-samples, liquid samples, organic samples, non-organic samples, small biomolecules, biomolecule fragments, proteins, peptides, or aptamers

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Dec 15, 2025 REM1
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Feb 24, 2021 ASGN
REGISTERED-PRINCIPAL REGISTER
Dec 15, 2020 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Nov 7, 2020 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Nov 6, 2020 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Oct 21, 2020 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 20, 2020 AITU
USE AMENDMENT FILED
Oct 5, 2020 IUAF
TEAS STATEMENT OF USE RECEIVED
Oct 5, 2020 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 7, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 11, 2020 NPUB
PUBLISHED FOR OPPOSITION
Feb 11, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 22, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 6, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 6, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 6, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 6, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 6, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 15, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 14, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 14, 2019 TROA
ASSIGNED TO EXAMINER
Sep 30, 2019 DOCK
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 14, 2019 GNRN
NON-FINAL ACTION E-MAILED
May 14, 2019 GNRT
NON-FINAL ACTION WRITTEN
May 14, 2019 CNRT
ASSIGNED TO EXAMINER
May 2, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 18, 2019 NWOS
NEW APPLICATION ENTERED
Mar 1, 2019 NWAP